ZH

Zheng Guanghui

  • CIK: 0002132285
  • EIN:
  • Business address:

Information

  • Mailing address
    ZHUBANG 2000 BUSINESS CENTER, NO. 97,BALIZHUANG XILI,CHAOYANG DISTRICT, BEIJING, 00000
  • Phone
    N/A
  • State location
    N/A
  • State of incorporation
    N/A
  • Fiscal year end
    N/A
  • SIC
    N/A
  • Filings
    N/A

About Zheng Guanghui

Zheng Guanghui (CIK: 0002132285) is an American company incorporated in the state of N/A. Head office is located at . Work in the industry N/A. Zheng Guanghui is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Zheng Guanghui

Filings Format Description Filed/Effective File/Film Number
3 Document

Initial statement of beneficial ownership of securities

Acc-no: 0001213900-26-060316 (34 Act) Size: 0 KB		 May-22-2026

001-39257

261010867

Recent 20 filings. View all Zheng Guanghui filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • Zheng Guanghui overview
  • Zheng Guanghui job
  • Zheng Guanghui stock
  • Zheng Guanghui ownership
  • Zheng Guanghui CEO
  • Zheng Guanghui documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Xu Wei XW
Update: May 23, 2026
Wang Andre
Update: May 23, 2026
Vicore Pharma Holdings AB / ADR
Update: May 23, 2026
Vicore Pharma Holding AB
Update: May 23, 2026
Tharisa plc
Update: May 23, 2026
Srirathan Niroshan
Update: May 23, 2026

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1328 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 2242 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4171 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2522 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1367 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 3037 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 2185 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1934 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4066 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by